Product Information
DROXIDOPA 300 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $2.7098 per EA under NDC 70710139109. Its NADAC has been published 158 times since Jun 21, 2023.
Strength
300 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710139109
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DROXIDOPAApproval Type
Generic (ANDA)
FDA Application
ANDA211818On Market Since
2/19/2021
Pharmacological Classes
Price Statistics
The NADAC for DROXIDOPA 300 MG CAPSULE has been published 158 times since Jun 21, 2023, and over the history we have for it it has risen 6.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7098 per EA |
|---|---|
| All-time high | $3.0478 (Nov 13, 2024) |
| All-time low | $2.1966 (Sep 17, 2025) |
| 52-week high | $2.8151 |
| 52-week low | $2.1966 |
| Median price | $2.5551 |
| Average price | $2.5833 |
| Largest weekly change | +12.0% (Aug 21, 2024) |
| Weeks tracked | 158 |
| Tracking since | Jun 21, 2023 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DROXIDOPA 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DROXIDOPA 300 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $2.7098 per EA (NDC 70710139109), effective Jun 24, 2026.
How has the price of DROXIDOPA 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DROXIDOPA 300 MG CAPSULE has risen 6.1%. It has been tracked across 158 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for DROXIDOPA 300 MG CAPSULE?
Since Jun 21, 2023, the NADAC for DROXIDOPA 300 MG CAPSULE has ranged from a low of $2.1966 (Sep 17, 2025) to a high of $3.0478 (Nov 13, 2024), with a median of $2.5551 per EA.
Are there cheaper alternatives to DROXIDOPA 300 MG CAPSULE?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DROXIDOPA 300 MG CAPSULE, is $2.2457 per EA — about 17% below DROXIDOPA 300 MG CAPSULE.
Who manufactures DROXIDOPA 300 MG CAPSULE?
DROXIDOPA 300 MG CAPSULE (NDC 70710139109) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification